Details of the Drug Reposition

General Information of This Drug (ID: DMUES7Y)

Drug Name
AB154   DMUES7Y
Synonyms Domvanalimab
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Non-small-cell lung cancer DISI0V1B 2C25 Phase 3 [1]
------------------------------------------------------------------------------------
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 1 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04736173) Study to Evaluate Monotherapy Compared to Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT03628677) A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies. U.S. National Institutes of Health.